Israel vs Italy: The number of people with susceptibility test result for rifampicin
Israel
100
in 2021
Italy
115.63
in 2021
Israel rank
2nd
Italy rank
1st
The number of people with susceptibility test result for rifampicin over time
- Israel
- Italy
How they compare
Italy currently reports 115.63 against 100 in Israel, a difference of 15.63.
That makes Italy's figure about 1.2 times Israel's.
Across all 5 years both countries report, Italy has been ahead every year.
Israel ranks 2nd and Italy ranks 1st of 146 countries.
Italy has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.2 | 105.53 | 7.34 | Italy |
| 2020s | 100 | 117.07 | 17.07 | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Israel or Italy?
- Italy, at 115.63 against 100 in Israel as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Israel and Italy?
- 15.63, with Italy ahead.
- How many years of comparable data are there for Israel and Italy?
- 5 years are reported by both, from 2017 to 2021.
- How do Israel and Italy rank globally for the number of people with susceptibility test result for rifampicin?
- Israel ranks 2nd and Italy ranks 1st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.